Pariser, David M.

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial

Pariser, D. M., Lowe, N. J., Stewart, D. M., Jarratt, M. T., Lucky, A. W., Pariser, R. J., & Yamauchi, P. S. (2003) · Journal of the American Academy of Dermatology

Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research Studies

Cited by 302

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up: AKs treated with ALA-PDT: a 12-month follow up

Tschen, E. H., Wong, D. S., Pariser, D. M., Dunlap, F. E., Houlihan, A., Ferdon, M. B., & the Phase IV ALA-PDT Actinic Keratosis Study Group (2006) · British Journal of Dermatology

Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research Studies

Cited by 157

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

Foley, P., Freeman, M., Menter, A., Siller, G., El‐Azhary, R. A., Gebauer, K., Lowe, N. J., Jarratt, M. T., Murrell, D. F., Rich, P., et al. (2009) · International Journal of Dermatology

Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research Studies

Cited by 92

Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial

Thiboutot, D., Pariser, D. M., Egan, N., Flores, J., Herndon, J. H., Kanof, N. B., Kempers, S. E., Maddin, S., Poulin, Y. P., Wilson, D. C., et al. (2006) · Journal of the American Academy of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 67

Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug

Stein Gold, L., Baldwin, H., Kircik, L. H., Weiss, J. S., Pariser, D. M., Callender, V., Lain, E., Gold, M., Beer, K., Draelos, Z., et al. (2022) · American Journal of Clinical Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 51

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail*

Elewski, B., Brand, S., Degenhardt, T., Curelop, S., Pollak, R., Schotzinger, R., Tavakkol, A., Alonso‐Llamazares, J., Ashton, S. J., Bhatia, N., et al. (2021) · British Journal of Dermatology

Nail Diseases and TreatmentsAntifungal resistance and susceptibility

Cited by 42